Transaction Breakdown
Companies & Roles
Discretionary Trading P&L
Holdings
Transaction History
About Stevens Christopher James
Stevens Christopher James (SEC CIK 0002079768) files insider reports with the SEC as Chief Operating Officer of ROCKET PHARMACEUTICALS, INC. (RCKT).
Signal8 holds 5 ownership filings by Stevens Christopher James (1 Form 3, 4 Form 4), filed between Aug 4, 2025 and Aug 13, 2026. Those filings report 4 transactions, the latest on Aug 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Stevens Christopher James's filings is in CRANBURY, NJ.
Other insiders filing for ROCKET PHARMACEUTICALS, INC. (RCKT)
- Wilson Martin, General Counsel
- Shah Gaurav, CEO
- Chaudhuri Sarbani
- SOUTHWELL DAVID P, Director
- Manhede Joseph, Principal Accounting Officer
- WONG RODERICK, Director